Clobetasol Propionate
Back to searchMolecule Structure
Scientific Name
Clobetasol Propionate
Description of the Drug
Clobetasol propionate is a corticosteroid used to treat corticosteroid-responsive dermatoses and plaque psoriasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01013
http://www.drugbank.ca/drugs/DB01013
Brand Name(s)
Clarelux, Clobaderm, Clobetasol propionate, Clobetasol propionate (emollient), Clobex, Cormax, Dermovate, Dermovate nn, Embeline, Embeline e, Etrivex, Impeklo, Impoyz, Olux, Olux e, Temovate, Temovate e
Company Owner(s)
Macleods Pharmaceuticals Ltd, Fougera Pharmaceuticals Inc, Actavis Mid Atlantic Llc, Taro Pharmaceuticals Usa Inc, Glenmark Pharmaceuticals Sa, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3997 | ||||||
| PharmGKB | PA164744375 | ||||||
| DrugBank | DB01013 | ||||||
| PubChem: Thomson Pharma | 14858433 | ||||||
| PubChem | 32798 | ||||||
| LINCS | LSM-5281 | ||||||
| Nikkaji | J21.005F | ||||||
| PDBe | XRD | ||||||
| BindingDB | 39347 | ||||||
| EPA CompTox Dashboard | DTXSID6045907 | ||||||
| DrugCentral | 4452 | ||||||
| ChemicalBook | CB6274337 | ||||||
| Guide to Pharmacology | 7062 | ||||||
| rxnorm | CORMAX | TEMOVATE | CLOBEX | IMPOYZ | OLUX | CLOBETASOL | CLOBETASOL PROPIONATE |
| ChEBI | 31414 | ||||||
| ZINC | ZINC000003977767 |
